T De Witte - JoVE Visualize

Showing results (121-130 of 215) with videos related to

Pageof 22

Sort By:

Infection|January 1, 1992

Treatment of myelodysplastic syndromes (MDS) and high leukaemic risk with low-dose cytosine arabinoside (LD-AraC) plus granulocyte-macrophage colony-stimulating factor (rh GM-CSF). The EORTC Leukaemia GroupH H Gerhartz, R Marcus, A Delmer, et al.

Blood|May 16, 1998

Hematopoietic malignancies demonstrate loss-of-function mutations of BAXJ P Meijerink, E J Mensink, K Wang, et al.

British Journal of Haematology|October 23, 1997

Outcome of transplantation for standard-risk leukaemia with grafts depleted of lymphocytes after conditioning with an intensified regimenN Schaap, A Schattenberg, B Bär, et al.

Leukemia|January 1, 1994

Treatment of patients with acute promyelocytic leukemia. The EORTC-LCG experience. EORTC Leukemia Cooperative GroupR Willemze, S Suciu, F Mandelli, et al.

Annals of Hematology|June 1, 1996

A long-lasting, complete hematologic and cytogenetic remission of chronic myelogenous leukemia after treatment with busulfan aloneC M Mandigers, E J Mensink, A Geurts van Kessel, et al.

British Journal of Haematology|November 1, 1988

Relationship between internalization and cytotoxicity of ricin A-chain immunotoxinsF W Preijers, W J Tax, T De Witte, et al.

Leukemia|December 26, 2001

Degradable dU-based DNA template as a standard in real-time PCR quantitationJ L Pennings, L T Van De Locht, J H Jansen, et al.

Leukemia|January 1, 1994

A randomized phase II study of low-dose cytosine arabinoside (LD-AraC) plus granulocyte-macrophage colony-stimulating factor (rhGM-CSF) in myelodysplastic syndromes (MDS) with a high risk of developing leukemia. EORTC Leukemia Cooperative GroupH H Gerhartz, R Marcus, A Delmer, et al.

Annals of Hematology|May 1, 1993

Proliferation patterns in acute myeloid leukemia: leukemic clonogenic growth and in vivo cell cycle kineticsP P Brons, C Haanen, J B Boezeman, et al.

The New England Journal of Medicine|January 26, 1995

Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) Leukemia Cooperative GroupsR A Zittoun, F Mandelli, R Willemze, et al.

Pageof 22

Showing results (121-130 of 215) with videos related to

Sort By:

Pageof 22

Infection|January 1, 1992

Treatment of myelodysplastic syndromes (MDS) and high leukaemic risk with low-dose cytosine arabinoside (LD-AraC) plus granulocyte-macrophage colony-stimulating factor (rh GM-CSF). The EORTC Leukaemia GroupH H Gerhartz, R Marcus, A Delmer, et al.

Blood|May 16, 1998

Hematopoietic malignancies demonstrate loss-of-function mutations of BAXJ P Meijerink, E J Mensink, K Wang, et al.

British Journal of Haematology|October 23, 1997

Outcome of transplantation for standard-risk leukaemia with grafts depleted of lymphocytes after conditioning with an intensified regimenN Schaap, A Schattenberg, B Bär, et al.

Leukemia|January 1, 1994

Treatment of patients with acute promyelocytic leukemia. The EORTC-LCG experience. EORTC Leukemia Cooperative GroupR Willemze, S Suciu, F Mandelli, et al.

Annals of Hematology|June 1, 1996

A long-lasting, complete hematologic and cytogenetic remission of chronic myelogenous leukemia after treatment with busulfan aloneC M Mandigers, E J Mensink, A Geurts van Kessel, et al.

British Journal of Haematology|November 1, 1988

Relationship between internalization and cytotoxicity of ricin A-chain immunotoxinsF W Preijers, W J Tax, T De Witte, et al.

Leukemia|December 26, 2001

Degradable dU-based DNA template as a standard in real-time PCR quantitationJ L Pennings, L T Van De Locht, J H Jansen, et al.

Leukemia|January 1, 1994

A randomized phase II study of low-dose cytosine arabinoside (LD-AraC) plus granulocyte-macrophage colony-stimulating factor (rhGM-CSF) in myelodysplastic syndromes (MDS) with a high risk of developing leukemia. EORTC Leukemia Cooperative GroupH H Gerhartz, R Marcus, A Delmer, et al.

Annals of Hematology|May 1, 1993

Proliferation patterns in acute myeloid leukemia: leukemic clonogenic growth and in vivo cell cycle kineticsP P Brons, C Haanen, J B Boezeman, et al.

The New England Journal of Medicine|January 26, 1995

Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) Leukemia Cooperative GroupsR A Zittoun, F Mandelli, R Willemze, et al.

Pageof 22